Cindy Tahl - 09 Jan 2026 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief Legal and Compliance Officer
Signature
/s/ Cindy Tahl
Issuer symbol
FATE
Transactions as of
09 Jan 2026
Net transactions value
-$11,275
Form type
4
Filing time
12 Jan 2026, 16:04:22 UTC
Previous filing
05 Aug 2025
Next filing
16 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TAHL CINDY Chief Legal and Compliance Officer C/O FATE THERAPEUTICS, INC., 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO /s/ Cindy Tahl 12 Jan 2026 0001655472

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale $11,275 -10,589 -2.7% $1.06 387,081 09 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 17,500 shares of Common Stock underlying RSUs granted to the Reporting Person on January 15, 2025 and 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.
F2 Represents the weighted average sale price of the shares sold ranging from $1.05 to $1.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Remarks:

Chief Legal and Compliance Officer